To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression

Nuclear Medicine and Biology

Volumn 30, Issue 6, 2003, Pages 627-632

  Kuo, Tsung Huai ^a   Liu, Feng Yu ^b   Chuang, Cheng Yen ^a   Wu, Hurng Sheng ^a   Wang, Jhi Joung ^c   Kao, Albert ^d  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chemotherapy response; Lung resistance related protein; Multidrug resistance related protein 1; P glycoprotein; Small cell lung cancer; Technetium 99m tetrofosmin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG SMALL CELL CANCER; MALE; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; THORAX RADIOGRAPHY; TISSUE SECTION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0142106849     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00058-1     Document Type: Article

References (29)

1. Smit E.F., Postmus P.E. Chemotherapy of small cell lung cancer. Carney D.N. Lung Cancer. 1995;156-172 The Bath Press, Avon, London.
2. Berlin J., Schiller J.H. Chemotherapy of small-cell carcinoma of the lung. Johnson B.E., Johnson D.H. Lung Cancer. 1995;247-261 Wiley-Liss, New York.
3. Lassen U., Hansen H.H. Small cell carcinoma of the lung. Haskell C.M., Berek J.S. Cancer Treatment. 1995;414-420 W. B. Saunders, Phildelphia.
4. Brock I., Hipfner D.R., Nielsen B.S., Jensen P.B., Deeley R.G., Cole S.P.C. Sequential coexpression of the multidrug resistance gene MRP and mdr1 and their products in products in VP-16 (Etoposide)-selected H69 small cell lung cancer cells. Cancer Res. 55:1995;459-462.
5. Narasaki F., Matsuo I., Ikuno N., Fukuda M., Soda H., Oka M. Multidrug resistance - associated protein (MRP) gene expression in human lung cancer. Anticancer Res. 16:1996;2079-2082.
6. Twentyman P.R. Mechanism of drug resistance in lung cancer cells. Carney C.N. Lung Cancer. 1995;213-233 The Bath Press, London.
7. Volm M. Multidrug resistance and its reversal. Anticancer Res. 18:1998;2905-2918.
8. Scheper R.J., Broxterman H.J., Scheffer G.L., Kaaijk P., Dalton W.S., van Heijningen T.H., van Kalken C.K., Slovak M.L., de Vries E.G., van der Valk P., et al. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53:1993;1457-1459.
9. Izquierdo M.A., Shoemaker R.H., Flens M.J., Scheffer G.L., Wu L., Prather T.R., Scheper R.J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer. 65:1996;230-237.
10. Hendrikse N.H., Franssen E.J., van der Graaf W.T., Vaalburg W., de Vries E.G. Visualization of multidrug resistance in vivo. Eur J Nucl Med. 26:1999;283-293.
11. Ballinger J.R., Bannerman J., Boxen I., Firby P., Hartman N.G., Moore M.J. Technetium-99-tetrofosmin as a substrate for P-glycoprotein in vitro studies in multidrug-resistant breast tumor cells . J Nucl Med. 37:1996;1578-1582.
12. Kao C.H., Ho Y.J., Shen Y.Y., Lee J.K. Evaluation of chemotherapy response in patients with small cell lung cancer using technetium-99m- tetrofosmin. Anticancer Res. 19:1999;2311-2315.
13. Shiau Y.C., Tsai S.C., Wang J.J., Ho Y.J., Ho S.T., Kao C.H. To predict chemotherapy response using technetium-99m tetrofosmin and compare with p-glycoprotein and multidrug resistance related protein-1 expression in patients with untreated small cell lung cancer. Cancer Lett. 169:2001;181-188.
14. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden T.E., Carbone P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 5:1982;649-655.
15. Dingemans A.M.C., van Ark-Otte J., Span S., Scagliotti C.V., van der Valk P., Postmus P.E., Giaccone G. Topoisomerase Iiα and other drug resistance markers in advanced non-small cell lung cancer. Lung Cancer. 32:2001;117-128.
16. Filipits M., Jaeger U., Simonitsch I., Chizzali-Bonfadin C., Heinzl H., Pirker R. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas. Clin Cancer Res. 6:2000;3417-3423.
17. Dingemans A.M.C., van Ark-Otte J., van der Valk P., Apolinario R.M., Scheper R.J., Postmus P.E., Giaccone G. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncol. 7:1996;625-630.
18. Zhou J., Higashi K., Ueda Y., Kodama Y., Guo D., Jisaki F. Expression of multidrug resistance protein and messenger RNA correlate with 99mTc-MIBI imaging in patients with lung cancer. J Nucl Med. 42:2001;1476-1483.
19. Kreisholt J.J., Sorensen M., Jensen P.B., Nielsen B.S., Andersen C.B., Sehested M. Immunohistochemical detection of DNA topoisomerases II α, p-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer. Br J Cancer. 77:1998;1469-1473.
20. Chuman Y., Sumizawa T., Takwbayashi Y., Niwa K., Yamada K., Haraguchi M., Furukawa T., Akiyama S., Aikou T. Expression of the multidrug-resistance- associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int J Cancer. 66:1996;274-279.
21. Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., Pastan I. Expression of a multidurg-resistance gene in human tumors and tissue. Proc Natl Acad Sci USA. 84:1987;265-269.
22. Flens M.J., Zaman G.J., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., van der Groep P., de Haas M., Meijer C.J., Scheper R.J. Tissue distribution of the multidrug resistance protein. Am J Pathol. 148:1996;1237-1247.
23. Izquierdo M.A., Scheffer G.L., Flens M.J., Giaccone G., Broxterman H.J., Meijer C.J., van der Valk P., Scheper R.J. Broad distribution of the mutlidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol. 148:1996;877-887.
24. Kostakoglu L., Kiratli P., Ruacan S., Hayran M., Emri S., Ergun E.L., Bekdik C.F. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med. 39:1998;228-234.
25. Fukumoto M., Yoshida D., Hayase N., Kurohara A., Akagi N., Yoshida S. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study . Cancer. 86:1999;1470-1479.
26. Canitrot Y., Bichat F., Cole S.P., Deeley R.G., Gerlach J.H., Bastian G., Arvelo F., Poupon M.F. Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts relationship with response to chemotherapy . Cancer Lett. 130:1998;133-141.
27. Yang X., Page M. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin. Oncol Res. 7:1995;619-624.
28. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. Science. 258:1992;1650-1654.
29. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J., Clevers H.C., Scheper R.J. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 6:1995;578-582.